Download full-text PDF

Source
http://dx.doi.org/10.1159/000059951DOI Listing

Publication Analysis

Top Keywords

beta-2-microglobulin removal
4
removal hemodialysis
4
hemodialysis polymethylmethacrylate
4
polymethylmethacrylate membranes
4
beta-2-microglobulin
1
hemodialysis
1
polymethylmethacrylate
1
membranes
1

Similar Publications

Various high-efficiency hemodialysis techniques exist, including different online high- volume hemodiafiltration (HDF) modes and expanded hemodialysis (HDx) utilizing dialyzers with medium cut-off (MCO) membranes. This study aimed to evaluate the efficacy of uremic toxin removal among four modalities: (I) HDx, (II) pre-dilution HDF (PRE-HDF), (III) mixed-dilution HDF (MIX-HDF), and (IV) post-dilution HDF (POST-HDF), each applied for 1 week in a randomized order. This research was a single-center, prospective, open-label, exploratory crossover study.

View Article and Find Full Text PDF

Three-weekly 4-h hemodialysis/hemodiafiltration (HD/HDF) per week has become the "standard HD/HDF" regimen in children across the globe, although increasingly criticized, since crucial determinants such as residual kidney function and patient preferences are not considered. As a consequence, several children fail to achieve adequate dialysis while on a "standard HD/HDF." In these circumstances, an extended dialysis prescription such as short daily (2-3 h/session, 5-7 days a week) or nocturnal HD/HDF (6-9 h/session, 3-5 days a week), either at home or in a dialysis center, may be considered.

View Article and Find Full Text PDF

Introduction: New dialysis membranes with new properties are being developed to improve efficacy and tolerance. The hemocompatibility of a polymeric biomaterial is influenced by the layer of water at the blood membrane interface. The new dialyzer TORAY NV-U has a membrane Hydrolink™, designed to suppress platelet adhesion and to improve the hemocompatibility.

View Article and Find Full Text PDF

Randomized investigation of increased dialyzer membrane hydrophilicity on hemocompatibility and performance.

BMC Nephrol

July 2024

Fresenius Medical Care Deutschland GmbH, Global Biomedical Evidence Generation, Global Medical Office, 61352, Bad Homburg, Germany.

Background: Hemodialyzers should efficiently eliminate small and middle molecular uremic toxins and possess exceptional hemocompatibility to improve well-being of patients with end-stage kidney disease. However, performance and hemocompatibility get compromised during treatment due to adsorption of plasma proteins to the dialyzer membrane. Increased membrane hydrophilicity reduces protein adsorption to the membrane and was implemented in the novel FX CorAL dialyzer.

View Article and Find Full Text PDF
Article Synopsis
  • * The case study focuses on a 72-year-old male with swallowing difficulties and an EMP that didn't respond to radiation, but diagnosis excluded multiple myeloma.
  • * Successful treatment involved surgical removal of the EMP, followed by systemic therapy, leading to the patient's complete recovery and effective disease management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!